EMAMILTDNSEEmami Limited· Personal CareHighNeutral
Announced Thu, 21 May, 2026 · 13:53 IST

Emami Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

Revenue DeclinePat NegativeEbitda Margin CompressionExceptional ItemRelated Party TransactionsResults View source PDFExplain this filing

EMAMILTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-5.7%1-day move
₹427.05
prior close
₹434.15
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-3.3-4.9-5.1-4.7-5.7-5.3-5.2-6.2-6.5-8.3-8.5-4.8-6.1-5.7
Up moveDown movePending
AI summary

Emami Limited reported consolidated revenue from operations of ₹3,77,951 Lacs for FY2026, marginally down from ₹3,80,919 Lacs in FY2025. EBITDA declined to ₹1,04,876 Lacs from ₹1,09,322 Lacs, while PAT fell to ₹77,526 Lacs from ₹80,274 Lacs — representing a PAT decline of approximately 3.4% YoY. EBITDA margin compressed from 28.71% to 27.75%. An exceptional item of ₹1,015 Lacs was recorded related to new labour code provisions. S.R. Batliboi & Co. LLP issued an unmodified (clean) audit opinion on both standalone and consolidated results. Post-year-end, the company announced two acquisitions: remaining 73.5% stake in associate Axiom Ayurveda (up to ₹200 Cr) and 60% stake in IncNut Digital (up to ₹321 Cr).

Likely market impact

Revenue and profit both declined year-on-year, with margin compression indicating cost pressures. The clean audit opinion provides assurance, but the acquisitions announced post-year-end signal a shift toward growth through M&A, which could be earnings-accretive or debt-enhancing depending on structure.